Manulife (Manufacturers Life Insurance)’s BioNTech BNTX Stock Holding History
Bought
Maintained
Sold
Other funds holding BNTX
P
Manulife (Manufacturers Life Insurance)'s BNTX Position: Q1 2025 in Review
Manulife (Manufacturers Life Insurance) sold out of BioNTech (BNTX) in Q1 2025, closing a stake of 22,983 shares — an estimated $2.62M sold.
Manulife (Manufacturers Life Insurance) first reported a position in BNTX in Q1 2022 and held it in 6 quarters. The position peaked at $9.96M in Q1 2022. 280 funds tracked by Wall St. Rank hold BNTX as of Q1 2025.
- Manulife (Manufacturers Life Insurance) reported no remaining BioNTech position as of Q1 2025 after selling out during the quarter.
- Manulife (Manufacturers Life Insurance) sold 22,983 BioNTech shares in Q1 2025, an estimated $2.62M.
- Manulife (Manufacturers Life Insurance) first reported a position in BioNTech in Q1 2022 and held it in 6 quarters.
- Manulife (Manufacturers Life Insurance)'s BioNTech position peaked at $9.96M in Q1 2022.
- 280 funds tracked by Wall St. Rank held BioNTech as of Q1 2025.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2025, filed 15 May 2025.